New Mexico, Colorado, Oregon, Washington, and Minnesota are among states looking at “Medicaid buy-in” proposals as a way to offer more affordable healthcare options; the return of measles is creating a backlash against critics of vaccines; first responders who worked during and after the 9/11 terror attacks and their advocates urged Congress to ensure that the September 11th Victim Compensation Fund does not run out of money.
New Mexico, Colorado, Oregon, Washington, and Minnesota are among states looking at “Medicaid buy-in” proposals as a way to offer more affordable healthcare options, Kaiser Health News reported. A report commissioned by New Mexico projected that up to 16,000 people would enroll in such a program, and their premiums would be 15% to 28% lower than plans sold on the individual market.
The return of measles is creating a backlash against critics of vaccines, The Washington Post reported. Washington state is moving forward with 2 measures that would bar parents from using personal or philosophical exemptions to avoid immunizing their school-aged children; in Washington, the worst measles outbreak in more than 2 decades has sickened nearly 70 people and cost over $1 million. Similar efforts are building in Arizona, Iowa, and Minnesota, as well as Vermont and New Jersey.
First responders who worked during and after the 9/11 terror attacks and their advocates urged Congress to ensure that the September 11th Victim Compensation Fund does not run out of money, the Associated Press reported. Joined by comedian Jon Stewart, members of the New York delegation and the advocates blasted an announcement by the Justice Department that the fund is running out and future payments may be cut by up to 70%. Fund officials estimate that it would take another $5 billion to pay pending claims and claims that officials anticipate will be submitted before the fund’s December 2020 deadline. Many responders have seen their health decline, some with respiratory or digestive system ailments that appeared almost immediately and others with illnesses that developed as they aged, including cancer.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen